Presseaussendungen zu "Bavencio"

21 Aussendungen
vorige Seite Seite 1 von 2 nächste Seite

OTE0003
19.11.2018 13:09
OTE0001
09.10.2018 08:01

FDA Grants Breakthrough Therapy Designation for Avelumab in Combination with INLYTA® in Advanced Renal Cell Carcinoma

Merck and Pfizer Inc. (NYSE: PFE) today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for avelumab in combination with INLYTA® (axitinib)* for …

OTE0005
21.12.2017 19:11
in Chronik

Bavencio (avelumab) Approved for Merkel Cell Carcinoma in Japan

Not intended for US, Canadian and UK-based media

OTE0002
27.09.2017 10:05
OTE0001
21.09.2017 09:14
vorige Seite nächste Seite